Shannon Corona

CinRx Pharma

CinRx Pharma is a mosaic of biotechnology companies supported by a dedicated funding mechanism designed to improve drug development success by accelerating promising new medicines to patients. Integrating our pre-clinical, clinical and operational expertise with multiple shots on goal, we customize the optimal development trajectory for each pipeline candidate – a drug development superhighway. Our deliberate approach to asset selection is driven by deep operational and scientific expertise combined with decades of experience treating patients and developing new drugs. We invest in candidate drugs that have the potential for transformational change in the way a disease area is treated and significantly improves the patient experience and quality of life.